Novel Immunomodulatory effect of miR-142 / ROCK2 Axis, on Leishmania infected macrophages

Inside the human body, a silent war often plays out within the microscopic chambers of our immune system. The frontline soldiers in this conflict are macrophages, a type of white blood cell designed to hunt down and destroy invaders. When a parasite called Leishmania enters the body through the bite of a sand fly, it hides inside these very cells. The outcome of the infection depends on how the macrophage reacts. Sometimes, the cell wakes up and becomes a fierce warrior, pumping out toxic chemicals to kill the parasite. Other times, the parasite tricks the cell into becoming a quiet, passive host, allowing it to multiply and spread. This shift between an aggressive state and a passive one is known as polarization, and finding a way to force the cell back into a fighting mood could be the key to curing a disease that affects millions of people worldwide.

A team of researchers at the Pasteur Institute of Iran and other universities has uncovered a specific molecular switch that controls this behavior. They focused on a tiny molecule called miR-142, which acts like a dimmer switch for a protein named ROCK2. In simple terms, ROCK2 is a protein that helps the macrophage relax and become passive, a state that favors the parasite's survival. The researchers discovered that when the body is infected, the levels of miR-142 drop, allowing ROCK2 to rise and the cell to become passive. However, by artificially boosting the levels of miR-142 in the lab, they were able to turn down the ROCK2 protein, forcing the macrophage to stay in its aggressive, parasite-killing mode.

The study began by looking at how these cells behave when they are healthy versus when they are infected. The scientists took bone marrow from mice and grew them into macrophages in a dish. They confirmed that these cells could be trained to be either aggressive or passive. When trained to be aggressive, the cells showed high levels of miR-142 and low levels of ROCK2. When trained to be passive, the opposite occurred. The researchers then infected these cells with Leishmania major, a common species of the parasite. They observed that the infection naturally caused the cells to lower their miR-142 levels. This drop allowed ROCK2 to increase, which in turn helped the parasite survive and multiply inside the cell. It appeared the parasite was successfully hijacking the cell's internal machinery to keep it quiet.

To test if they could reverse this process, the scientists introduced a genetic tool into the cells to force them to produce extra miR-142. They used a vector, a delivery vehicle made of genetic material, to insert the instructions for making this molecule directly into the macrophages. The experiment was highly efficient, with more than 80 percent of the cells successfully taking up the new instructions. Once the cells were flooded with miR-142, the results were immediate and clear. The levels of the ROCK2 protein dropped significantly. Because ROCK2 was suppressed, the cells did not switch to the passive state. Instead, they remained in their aggressive, pro-inflammatory mode.

The consequences of this change were dramatic. In the cells where miR-142 was boosted, the number of parasites inside dropped sharply. The cells produced high levels of toxic chemicals, specifically nitric oxide, which are known to destroy the parasite. At the same time, the production of substances that usually help the parasite survive, such as arginase, was reduced. The researchers also checked the levels of various signaling molecules, or cytokines, that tell the immune system what to do. They found that the boosted cells released more of the signals that trigger an attack and fewer of the signals that calm the immune system down. This confirmed that the cells were not just surviving the infection but were actively fighting it.

The study also looked at a specific surface marker called CD200, which the parasite uses to send inhibitory signals to the cell, telling it to stop fighting. In the cells with high levels of miR-142, the expression of this marker was reduced, further preventing the parasite from silencing the immune response. The researchers verified these findings using multiple methods, including microscopic observation of the cells and chemical tests to measure protein levels. They confirmed that the reduction in ROCK2 was not just a temporary fluctuation but a sustained change that directly correlated with the lower parasite load.

This work highlights a precise mechanism by which a parasite manipulates its host and how that manipulation can be countered. The researchers did not claim to have a cure for the disease, but they demonstrated that the miR-142 and ROCK2 pathway is a critical control point. By understanding that miR-142 acts as a selective inhibitor of ROCK2, they showed that it is possible to tip the balance back in favor of the host. The findings suggest that the parasite's ability to survive relies on keeping miR-142 levels low, and that artificially raising these levels can restore the cell's natural ability to kill the invader. This provides a clear, molecular target for future research into how to treat leishmaniasis, offering a potential path to reawaken the immune system's defenses against a persistent and dangerous pathogen.